secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVITA Medical, Inc. (RCEL)
CIK:        0001762303
Form:       8-K
Filed at:   2023-03-27T23:59:59+00:00
Accession:  0001193125-23-080474
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AVITA Medical appoints Robert McNamara to board, sets 2023 annual meeting
-------------------------------------------------------------------------

- Robert McNamara appointed to Board of Directors effective April 1, 2023.
- McNamara receives $70K annual cash, $210K initial equity, $105K annual equity (subject to shareholder approval).
- McNamara has 25+ years of med-tech leadership; currently on boards of Axonics, Teknova, Xtant Medical.
- 2023 Annual Meeting scheduled for June 6, 2023 via live audio webcast.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1762303/000119312523080474/0001193125-23-080474-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1762303/000119312523080474/d468715d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-080474

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer